Literature DB >> 22488170

GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol.

Qiang Li1, Yichen Ling, Long Yu.   

Abstract

PURPOSE: The aim of this study is to investigate whether GDF3 is related to the progression of human breast cancer and the effects of GDF3 on breast cancer cells.
METHODS: The expression of GDF3 in 24 breast cancer specimens paired with corresponding neighboring nontumorous tissue was studied by Western blot. Breast cancer cells were treated with different concentrations of recombinant human GDF3 protein. Using lentivirus containing sh-RNA, we knocked down the expression of GDF3. Soft agar assay was performed to explore the effects of GDF3 on colony formation. Different anti-tumor drugs dealt with MCF-7 cells stably expressing GDF3.
RESULTS: We found that GDF3 expression level was significantly down-regulated in breast cancer tissues compared to the surrounding nontumorous tissues. GDF3 proteins could inhibit the proliferation of MCF-7 and T47D cells. We also found that the knockdown of GDF3 resulted in the promotion of colony formation and enhanced the ability of anchorage-independent cell growth in soft agar. Furthermore, overexpression of GDF3 could promote the apoptosis induced by Taxol.
CONCLUSIONS: Our data indicated that GDF3 expression is significantly decreased in human breast cancer tissues, and reconstitution of GDF3 in breast cancer may be a potential therapeutic approach to inhibit aggressive growth of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488170     DOI: 10.1007/s00432-012-1213-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

Review 1.  Two major Smad pathways in TGF-beta superfamily signalling.

Authors:  Keiji Miyazawa; Masahiko Shinozaki; Takane Hara; Toshio Furuya; Kohei Miyazono
Journal:  Genes Cells       Date:  2002-12       Impact factor: 1.891

Review 2.  What is transforming growth factor-beta (TGF-beta)?

Authors:  David Chin; Glen M Boyle; Peter G Parsons; William B Coman
Journal:  Br J Plast Surg       Date:  2004-04

3.  Mechanisms in TGF-beta action.

Authors:  J Massagué; J Heino; M Laiho
Journal:  Ciba Found Symp       Date:  1991

4.  Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours.

Authors:  A A Caricasole; R H van Schaik; L M Zeinstra; C D Wierikx; R J van Gurp; M van den Pol; L H Looijenga; J W Oosterhuis; M F Pera; A Ward; D de Bruijn; P Kramer; F H de Jong; A J van den Eijnden-van Raaij
Journal:  Oncogene       Date:  1998-01-08       Impact factor: 9.867

5.  Transforming growth factor beta triggers two independent-senescence programs in cancer cells.

Authors:  Y Katakura; E Nakata; T Miura; S Shirahata
Journal:  Biochem Biophys Res Commun       Date:  1999-02-05       Impact factor: 3.575

6.  The conditioned medium from a stable human GDF3-expressing CHO cell line, induces the differentiation of PC12 cells.

Authors:  Qiang Li; Xianghua Liu; Yanhua Wu; Jian An; Saiyin Hexige; Yichen Ling; Mingjun Zhang; Xianmei Yang; Long Yu
Journal:  Mol Cell Biochem       Date:  2011-07-30       Impact factor: 3.396

7.  A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

Authors:  G Torre-Amione; R D Beauchamp; H Koeppen; B H Park; H Schreiber; H L Moses; D A Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

8.  Divergent effect of TGFbeta1 on growth and proteolytic modulation of human prostatic-cancer cell lines.

Authors:  S Desruisseau; E Ghazarossian-Ragni; O Chinot; P M Martin
Journal:  Int J Cancer       Date:  1996-06-11       Impact factor: 7.396

9.  Genomic profiling of tumor initiating prostatospheres.

Authors:  Maria Ana Duhagon; Elaine M Hurt; Jose R Sotelo-Silveira; Xiaohu Zhang; William L Farrar
Journal:  BMC Genomics       Date:  2010-05-25       Impact factor: 3.969

10.  Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.

Authors:  R R Perry; Y Kang; B R Greaves
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

View more
  6 in total

1.  A test for comparing two groups of samples when analyzing multiple omics profiles.

Authors:  Nimisha Chaturvedi; Jelle J Goeman; Judith M Boer; Wessel N van Wieringen; Renée X de Menezes
Journal:  BMC Bioinformatics       Date:  2014-07-08       Impact factor: 3.169

2.  Growth and differentiation factor 3 induces expression of genes related to differentiation in a model of cancer stem cells and protects them from retinoic acid-induced apoptosis.

Authors:  Karolina Tykwinska; Roland Lauster; Petra Knaus; Mark Rosowski
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

3.  Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence.

Authors:  Mauro Finicelli; Giovanni Benedetti; Tiziana Squillaro; Barbara Pistilli; Andrea Marcellusi; Paola Mariani; Alfredo Santinelli; Luciano Latini; Umberto Galderisi; Antonio Giordano
Journal:  Oncotarget       Date:  2014-10-30

4.  Six-mRNA risk score system and nomogram constructed for patients with ovarian cancer.

Authors:  Qianqian Wang; Zhuwu Lu; Jinqi Ma; Qingsong Zhang; Ni Wang; Li Qian; Jun Zhang; Chen Chen; Bei Lu
Journal:  Oncol Lett       Date:  2019-05-27       Impact factor: 2.967

5.  A risk model of gene signatures for predicting platinum response and survival in ovarian cancer.

Authors:  Siyu Chen; Yong Wu; Simin Wang; Jiangchun Wu; Xiaohua Wu; Zhong Zheng
Journal:  J Ovarian Res       Date:  2022-03-31       Impact factor: 4.234

6.  Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with Wilms tumour.

Authors:  Xiao-Mao Tian; Bin Xiang; Li-Ming Jin; Tao Mi; Jin-Kui Wang; Chenghao Zhanghuang; Zhao-Xia Zhang; Mei-Ling Chen; Qin-Lin Shi; Feng Liu; Tao Lin; Guang-Hui Wei
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.